What is Multisystem Inflammatory Syndrome
Mask and Vaccine Mandates a Sick and Twisted Game of Simon Says!!
The Very Real Consequences of Breast Implant Surgery
In a recent episode of the Medical Truth Podcast hosted by James Egidio, the dark side of breast augmentation surgery and its potential health risks were discussed. Dr. Shahar Khan, a double-boarded plastic surgeon, shared invaluable insights into the issues surrounding breast implants and the growing awareness of breast implant illness (BII). This blog post summarizes the key points discussed in the podcast episode.
Breast Augmentation Popularity:
Breast augmentation surgery has been one of the most popular cosmetic procedures in the United States for years. In 2021 alone, there were 364,753 breast augmentations, second only to liposuction.
Dr. Shahar Khan's Unique Practice:
Dr. Khan's medical practice stands out in the plastic surgery field because it is exclusively devoted to the removal of breast implants (both saline and silicone) and their associated capsules. Unlike many plastic surgeons, he chose not to perform breast augmentation surgeries, as he had witnessed the harm caused by breast implants during his medical training.
Breast Implant Illness (BII):
Dr. Khan discussed the concept of Breast Implant Illness (BII), a condition in which patients experience a wide range of symptoms and health issues attributed to their breast implants. These symptoms can include hair loss, migraines, anxiety, depression, joint pain, and more.
Causes of BII:
The primary cause of BII is the body's immune response to the foreign materials used in breast implants. Silicon dioxide, platinum, heavy metals, and other chemicals in breast implants can trigger an autoimmune response, leading to chronic inflammation.
Silicone Implant Ruptures:
Silicone implants, which are commonly used in breast augmentation, can rupture over time. This rupture can release silicone particles into the body, leading to further health complications and toxicity.
FDA Warnings:
Dr. Khan highlighted key warnings issued by the FDA regarding breast implants. These warnings include the fact that breast implants are not meant to be in the body forever, the risk of breast implant-associated lymphoma (BIA-ALCL), and reports of symptoms resolving after implant removal.
Immune Responses and Autoimmune Diseases:
Breast implants can exacerbate autoimmune diseases in individuals who are already susceptible. Patients with autoimmune issues, such as multiple sclerosis or Crohn's disease, are advised against getting breast implants.
The Role of Capsular Contracture:
Capsular contracture is a common complication of breast implants. It occurs when the scar tissue surrounding the implant becomes tight and painful. This can further impact a patient's health and quality of life.
FDA's Role and Patient Advocacy:
While the FDA has taken steps to address breast implant-related issues, such as banning textured implants and implementing black box warnings, Dr. Khan believes there is more that can be done. He highlights the need for the FDA to take a more assertive stance by recalling breast implants and protecting patients' well-being.
Dr. Khan commends the proactive role that patients are playing in advocating for their health. Patients are increasingly sharing their experiences and raising awareness of BII through social media, support groups, and discussions with other patients. Their voices are helping override misconceptions about breast implant safety and encouraging informed decision-making.
Conclusion:
Breast implant illness is a complex condition that requires careful diagnosis and surgical treatment. Dr. Khan's expertise and commitment to patient care shine through in his approach to explant surgery. Patients seeking relief from BII should prioritize finding a surgeon who acknowledges the condition and has a track record of complete capsule removal.
As the discussion around BII continues to evolve, patients, healthcare providers, and regulatory bodies like the FDA must work together to ensure the safety and well-being of individuals with breast implants. Education, transparency, and advocacy are crucial in addressing this important healthcare issue.
Share this post